CRIS Current Research Information System

BRODOSI, LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.269
NA - Nord America 3.189
EU - Europa 2.078
AF - Africa 208
SA - Sud America 195
OC - Oceania 2
Totale 9.941
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.129
SG - Singapore 1.181
CN - Cina 1.048
VN - Vietnam 943
IT - Italia 448
HK - Hong Kong 364
GB - Regno Unito 321
DE - Germania 283
SE - Svezia 248
IN - India 204
FR - Francia 178
KR - Corea 167
BR - Brasile 138
NL - Olanda 121
FI - Finlandia 99
IE - Irlanda 89
RU - Federazione Russa 86
JP - Giappone 78
ZA - Sudafrica 52
CI - Costa d'Avorio 43
SC - Seychelles 43
PH - Filippine 38
BG - Bulgaria 35
CA - Canada 34
ID - Indonesia 34
UA - Ucraina 28
JO - Giordania 27
NG - Nigeria 25
TH - Thailandia 23
TR - Turchia 23
AT - Austria 21
PL - Polonia 21
BD - Bangladesh 20
CH - Svizzera 20
AR - Argentina 19
PK - Pakistan 19
TG - Togo 19
GR - Grecia 18
IQ - Iraq 17
MX - Messico 16
BE - Belgio 15
SA - Arabia Saudita 14
MY - Malesia 13
TW - Taiwan 13
ES - Italia 11
IR - Iran 11
EC - Ecuador 10
EE - Estonia 9
EG - Egitto 8
LT - Lituania 8
CL - Cile 6
CO - Colombia 6
PE - Perù 6
RO - Romania 6
YE - Yemen 6
NP - Nepal 5
AZ - Azerbaigian 4
LB - Libano 4
PY - Paraguay 4
AO - Angola 3
DZ - Algeria 3
ET - Etiopia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
BO - Bolivia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
JM - Giamaica 2
LY - Libia 2
MA - Marocco 2
NO - Norvegia 2
RS - Serbia 2
TN - Tunisia 2
UY - Uruguay 2
VE - Venezuela 2
GH - Ghana 1
HR - Croazia 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
QA - Qatar 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 9.941
Salva come PNG Salva come JPEG
Città #
Singapore 824
Ashburn 458
Hefei 345
Hong Kong 344
Southend 240
Chandler 233
Hanoi 220
Ho Chi Minh City 212
Santa Clara 181
San Jose 175
Seoul 151
Fairfield 150
Dallas 127
Bologna 125
Beijing 108
Los Angeles 100
Princeton 97
Dublin 89
Seattle 88
Boardman 86
Helsinki 84
Houston 77
Woodbridge 76
Council Bluffs 65
Lauterbourg 65
Dong Ket 63
Wilmington 59
Tokyo 56
Redmond 53
Cambridge 49
Ann Arbor 48
Abidjan 43
Bengaluru 40
New York 38
Milan 37
Johannesburg 35
Munich 34
Sofia 34
Frankfurt am Main 33
Da Nang 31
Redondo Beach 31
Haiphong 29
Guangzhou 28
Abeokuta 25
Amman 25
Des Moines 25
Rome 25
Berlin 24
Buffalo 24
Medford 23
San Diego 22
Shanghai 22
Turin 22
London 20
Lomé 19
São Paulo 18
Westminster 17
Jakarta 16
Amsterdam 15
Brussels 15
Warsaw 14
Atlanta 13
Falkenstein 13
Jinan 13
Montreal 13
Padova 13
Paris 13
Düsseldorf 12
Kuala Lumpur 12
Lappeenranta 12
Parma 12
Tongling 12
Chicago 11
Dhaka 11
Hyderabad 11
Hải Dương 11
Nanjing 11
Nuremberg 11
Orem 11
Vienna 11
Zhengzhou 11
Biên Hòa 10
Jacksonville 10
Bangkok 9
Bern 9
Brooklyn 9
Chennai 9
Florence 9
Istanbul 9
Saint Petersburg 9
Wuhan 9
Bremen 8
Can Tho 8
Islamabad 8
Karbala 8
Phoenix 8
Shenzhen 8
Tân Tiến 8
Ankara 7
Cesena 7
Totale 6.231
Salva come PNG Salva come JPEG
Nome #
An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers 259
Liver Stiffness measurments using Fibroscan after three months of IFN-based antiviral therapy is unlikely to predict viral response in cirrhotic patients. 231
A new prognostic model to predict drop-out from the waiting list in cirrhotic candidates for liver transplantation wirh MELD score <18. 225
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation. 217
Long-term weight loss maintenance for obesity: A multidisciplinary approach 209
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus 208
Diabetes and NAFLD: a high-risk cohort with definite therapeutic potential 208
Diagnostic Performance of PIVKA-II in Italian Patients with Hepatocellular Carcinoma 193
Eating habits in patients affected by metabolic syndrome and liver disease (hepatitis, cirrhosis and liver transplant) 192
Long-term follow-up of web-based and group-based behavioural intervention in NAFLD in a real world clinical setting 191
Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels. 189
Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report. 189
Malnutrition and nutritional therapy in patients with SARS-CoV-2 disease 187
Lifestyle changes for the treatment of nonalcoholic fatty liver disease-a 2015-19 update 173
Lifestyle Intervention in NAFLD: Long-Term Diabetes Incidence in Subjects Treated by Web- and Group-Based Programs 171
Real-world prevalence of metabolic associated fatty liver disease (MAFLD) and fibrotic-non-alcoholic steatohepatitis (NASH) in patients with obesity (PwO) in an outpatient specialist clinic in Italy 171
Real-life prevalence of Metabolic Associated Fatty Liver Disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in a tertiary obesity clinic in Italy 164
Management of non-alcoholic fatty liver disease 164
CD 133+ stem cells for the treatment of end stage liver disease. 160
Moderate Alcohol Intake in Non-Alcoholic Fatty Liver Disease: To Drink or Not to Drink? 160
Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: a phase I clinical trial 159
Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease 156
A cross-sectional study on the prevalence of eating disorders in liver transplanted patients with type 2 diabetes and/or overweight/obesity 154
Burden of non-alcoholic fatty liver disease and usefulness of non-invasive tests to identify advanced liver disease in patients with type 2 diabetes mellitus: interimanalysis of an Italian prospective multicentre study 152
Fatty liver in pregnancy: a narrative review of two distinct conditions 151
Dati preliminari sullo studio della sintomatologia ortoressica tra pazienti diabetici affetti da epatopatia. 149
Symptoms of SARS-CoV-2 infection and vaccine status of sixty-seven adult patients affected by inherited metabolic diseases: a phone survey 147
Pegvaliase therapy for phenylketonuria: Real-world case series and clinical insights 146
Development of psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects. 146
Maternal PKU: Defining phenylalanine tolerance and its variation during pregnancy, according to genetic background 145
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: which is the winner? 145
Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity 143
Nutrition in patients with type 2 diabetes: Present knowledge and remaining challenges 140
Uno studio retrospettivo su 590 soggetti: sintomi psichiatrici durante la terapia antivirale per l’epatite cronica C. 139
Pathophysiology of Nonalcoholic Fatty Liver Disease: Lifestyle-Gut-Gene Interaction 137
Malnutrition in hospitalized patients with SARS-CoV-2 infection 132
Obesity and NAFLD: Same problem? 130
Caloric input is inadequate in predicting the presence of liver steatosis and fibrosis in a population adhering to a screening program for metabolic syndrome 126
The treatment of diabetes in advanced liver disease: change of a paradigm 123
Bone marrow derived stem cells for the treatment of end-stage liver disease. 122
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis 121
The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis. 117
COMBINATION study: COMbined Behavioural/INcretin Action sTudy In Obese/diabetic persoNs 117
Effect of physical exercise on postural control in diabetic subjects 115
NASH: A glance at the landscape of pharmacological treatment 112
Capitolo 14 "Epatiti Virali Croniche", Volume IX "Malattie del Fegato, delle Vie Biliari e del Pancreas", Trattato di Medicina Interna, fondato da Paolo Larizza 112
Psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects 112
The Effect of Liraglutide on β-Blockade for Preventing Variceal Bleeding: A Case Series 108
Considerations when prescribing pharmacotherapy for metabolic associated fatty liver disease 108
CD133+ hematopoietic stem cells reinfusion in end-stage liver disease (ESLD): final results of a phase I clinical trial 106
CD133+ stem cells for the treatment of end-stage liver disease 104
Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients 102
The management of transitional care of patients affected by phenylketonuria in Italy: Review and expert opinion 98
Effects of physical exercise on autonomic control in diabetic patients. 95
Web-based counseling for NAFLD. Final results. 95
'Effect of exercise training on postural control in people with diabetes 94
Undiagnosed Phenylketonuria Can Exist Everywhere: Results From an International Survey 93
NEUROD1 mutation in an Italian patient with maturity onset diabetes of the young 6: a case report 90
Impact of exercise training on postural control in people with diabetes. 90
Reinfusion of highly purified CD133+ stem cells in patients with end-stage liver disease (ESLD): final results of a phase I clinical trial 87
Management of patients with phenylketonuria (PKU) under enzyme replacement therapy: An Italian model (expert opinion) 82
Exercise-induced changes in postural stability among patients with diabetes 81
Relationship Between Physical Activity and Autonomic Responses in Adults with Type 2 Diabetes 79
Increased survival after sustained virological response in liver transplanted patients with HCV recurrence: taking-up a challenge for the hepatologist. 67
Effect of six months of exercise program on eye movements of diabetic people. 66
Benefits of a prolonged-release amino acid mixture in four pregnant women with phenylketonuria 66
Increased survival after sustained virological response in liver transplanted patients with HCV recurrence: taking-up a challenge for the hepatologist. 66
A modified Child-Turcotte-Pugh (CTP) for selection of candidates to liver transplantation (LT) with low model for end-stage liver disease score (MELD). 65
NAFLD, the hepatic manifestation of the metabolic syndrome 65
Hepatitis C recurrence after liver transplantation: do patients with mild disease need to be treated? 63
A modified Child-Turcotte-Pugh (CTP) for selection of patients affected by cirrhosis candidates for liver transplantation (LT) with low model for end-stage liver disease score (MELD) 63
Seven score systems to evaluate candidates to orthotopic liver transplantation: which is the winner? 60
Looking ahead to potential incretin combination therapies for nonalcoholic steatohepatitis in patients with diabetes 58
The role of physical activity on autonomic functions in diabetic patients 57
Impact of exercise protocol on postural control in people with diabetes 54
Natremia and Child-Turcotte-Pugh (CTP) score may improve the selection of candidates for liver transplantation (LT) with lower model for end-stage liver disease score (MELD) 53
Motor control evaluation in diabetic subjects 53
Effects of Physical Activity Level on Microsaccade Dynamics During Optic Flow Stimulation in Adults with Type 2 Diabetes 51
Natremia and Child-Turcotte-Pugh (CTP) may improve the selection of candidates for liver transplantation (LT) with lower model for end-stage liver disease score (MELD). 46
Night eating syndrome in liver transplant recipients with diabetes or excess-weight: a cross-sectional study 43
Transition in inherited metabolic diseases: the dietitians, pediatricians and adult physicians’ point of view: the results of an Italian survey 39
Effectiveness of a Model of Care Based on Fibrosis-4 and Liver Stiffness Measurement for the Screening of Patients With Type 2 Diabetes Mellitus at Risk of Advanced Liver Disease: Results From an Italian Prospective Multicenter Study 31
Lifetime physical activity and autonomic responses in adults with type 2 diabetes 28
NAFLD-Associated Hepatocellular Carcinoma: a Threat to Patients with Metabolic Disorders 18
NAFLD-Associated Hepatocellular Carcinoma: a Threat to Patients with Metabolic Disorders 14
null 1
Totale 10.148
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.976
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.976
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021130 0 0 0 0 0 0 0 0 0 20 5 105
2021/2022943 52 117 48 57 81 38 18 56 40 64 238 134
2022/20231.011 85 116 56 127 86 106 40 33 203 30 65 64
2023/2024463 42 69 33 43 35 83 14 48 18 39 13 26
2024/20251.966 77 230 172 190 254 71 117 74 52 151 146 432
2025/20264.806 446 499 483 466 483 243 638 202 988 358 0 0
Totale 10.148